هام أون لاين

US President Donald Trump announced yesterday that the US Food  and Drug Administration has allowed Gilead Sciences to urgently use its experimental anti-viral treatment, Remediesiver, to treat people with the emerging corona virus, as scientists compete globally to develop vaccines and treatments to reduce the pandemic. . The CEO of the company, Daniel Audi, described the procedure during a meeting with "Trump" at the White House, as an important first step, and said that the company donated a million and a half million doses of the drug to help patients, saying: "We want to make sure that there are no obstacles regarding The drug reaches those infected with the virus. Anthony Stephen Fuchi, the American immunologist, director of the National Institute of Allergy and Infectious Diseases, who works on the White House team to combat the virus, praised the clinical results of the  treatment, as it provided a glimmer of hope towards the treatment of the virus,...